Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03249168
Other study ID # MFGA
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date October 1, 2017
Est. completion date January 1, 2019

Study information

Verified date March 2019
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite recent advances in minimal invasive surgery, postoperative pain control remains a challenge for both surgeons and anesthesiologists . Currently, laparoscopy has an obvious favor for both diagnostic and therapeutic procedures of pelvic and abdomen; while it is minimally invasive, has less pain, and needs less postoperative analgesic use compared with open surgeries . Shoulder pain is a frequent problem following laparoscopic procedure


Description:

Many patients may feel much more discomfort from their shoulder pain than incision pain . Post laparoscopic shoulder pain is caused by irritation and/or injury of the diaphragm and phrenic nerve by local acidosis and irritative effect of carbon dioxide during pneumoperitoneum or distention forces on the diaphragm. Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor antidepressant . It is used to treat major depressive disorder in adults. Duloxetine is also used to treat general anxiety disorder. It is also used in adults to treat fibromyalgia (a chronic pain disorder), or chronic muscle or joint pain (such as low back pain and osteoarthritis pain). Duloxetine is also used to treat diabetic neuropathy. Previous studies focused on the use of gabapentin and pregabalin (both are antineuropathic pain medications) to prevent post laparoscopic shoulder pain after laparoscopic ovarian cystectomy and laparoscopic cholecystectomy showed favorable results and since duloxetine is an antineuropathic pain medications we assume its use will ameliorate diaphragmatic irritation and hencepost laparoscopic shoulder pain.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 1, 2019
Est. primary completion date November 1, 2018
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 45 Years
Eligibility Inclusion Criteria:

- Pre-menopausal females

- Patient consent

- Patients with ASA class I-II

- Elective gynecological laparoscopy

Exclusion Criteria:

- Body Mass Index = 40

- Consuming any pain killers routinely within 48 hours before the surgery

- Smoking, drug abuse

- Patients with major psychiatric disorders, epilepsy or history of convulsion

- Any known kidney or hepatic disorders

- History of any other pervious laparotomy, laparoscopy, or other pelvic manipulation or pathology except normal vaginal delivery

- History of chest or mediastinal surgery or pathology

- Recent flu (six weeks before surgery)

- Suspected to malignancy as pathology

- Those who complained from shoulder pain just before surgery in the first Visual Analog Scale assessment.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Duloxetine 60mg
tablet
Placebo
Tablet

Locations

Country Name City State
Egypt Faculty of Medicine, Assiut University Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Valadan M, Banifatemi S, Yousefshahi F. Preoperative Gabapentin to Prevent Postoperative Shoulder Pain After Laparoscopic Ovarian Cystectomy: A Randomized Clinical Trial. Anesth Pain Med. 2015 Dec 5;5(6):e31524. doi: 10.5812/aapm.31524. eCollection 2015 Dec. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary post laparoscopic shoulder pain The presence and severity of Post laparoscopic shoulder pain will be recorded using a Visual Analog Scale 12 hours after surgery
Secondary sedation Ramsey Sedation Scale 12 hours after surgery